- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eris Lifesciences Ltd (ERIS)
Eris Lifesciences Ltd stock price live, this page displays NSE ERIS stock exchange data. View the ERIS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Eris Lifesciences Ltd real time stock price chart below.
What Is the Eris Lifesciences Ltd Stock Price Today?
The Eris Lifesciences Ltd stock price today is 1,725.20.
What Is the Stock Symbol for Eris Lifesciences Ltd?
The stock symbol for Eris Lifesciences Ltd is ""ERIS.""
What Stock Exchange Does Eris Lifesciences Ltd Trade On?
Eris Lifesciences Ltd is listed and trades on the NSE stock exchange.
Is Eris Lifesciences Ltd a Good Stock to Buy?
Determining whether Eris Lifesciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ERIS quote. (ISIN: INE406M01024)
What Is the Eris Lifesciences Ltd Stock Price Today?
The Eris Lifesciences Ltd stock price today is 1,725.20.
What Is the Stock Symbol for Eris Lifesciences Ltd?
The stock symbol for Eris Lifesciences Ltd is ""ERIS.""
What Stock Exchange Does Eris Lifesciences Ltd Trade On?
Eris Lifesciences Ltd is listed and trades on the NSE stock exchange.
Is Eris Lifesciences Ltd a Good Stock to Buy?
Determining whether Eris Lifesciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ERIS quote. (ISIN: INE406M01024)
1,725.20
+30.60(+1.81%)
Closed·
Fair Value
An estimate of a Eris Lifesciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,680.00
1,745.90
52 wk Range
1,097.20
1,910.00
ERIS Scorecard
Full Analysis
Impressive gross profit margins
ERIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Eris Lifesciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,680.001,745.90
52 wk Range
1,097.201,910.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.43%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ERIS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Eris Lifesciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
1,852.50
Upside
+7.38%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Eris Lifesciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Eris Lifesciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell
Eris Lifesciences Ltd Company Profile
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
Compare ERIS to Peers and Sector
Metrics to compare | ERIS | Peers Peers - average of corresponding metrics from companies closely matching ERIS: SIGACHI, MOREPENLAB, LAURUSLABS, JBCHEPHARM, EMCURE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipERISPeersSector |
|---|---|---|---|---|
P/E Ratio | 60.8x | 29.8x | −0.5x | |
PEG Ratio | 38.89 | 0.76 | 0.00 | |
Price/Book | 8.2x | 3.8x | 2.6x | |
Price / LTM Sales | 8.0x | 4.4x | 3.3x | |
Upside (Analyst Target) | 8.1% | 13.5% | 43.4% | |
Fair Value Upside | Unlock | −0.4% | 7.1% | Unlock |
Analyst Ratings
9 Buy
1 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,852.50
(+7.38% Upside)
Earnings
Latest Release
Aug 05, 2025
EPS / Forecast
8.65 / 8.65
Revenue / Forecast
7.73B / 8.11B
People Also Watch
FAQ
What Stock Exchange Does Eris Lifesciences Trade On?
Eris Lifesciences is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Eris Lifesciences?
The stock symbol for Eris Lifesciences is "ERIS."
What Is the Eris Lifesciences Market Cap?
As of today, Eris Lifesciences market cap is 234.98B.
What Is Eris Lifesciences's Earnings Per Share (TTM)?
The Eris Lifesciences EPS (TTM) is 28.41.
When Is the Next Eris Lifesciences Earnings Date?
Eris Lifesciences will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is ERIS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Eris Lifesciences Stock Split?
Eris Lifesciences has split 0 times.
How Many Employees Does Eris Lifesciences Have?
Eris Lifesciences has 3354 employees.
What is the current trading status of Eris Lifesciences (ERIS)?
As of 10 Aug 2025, Eris Lifesciences (ERIS) is trading at a price of 1,725.20, with a previous close of 1,694.60. The stock has fluctuated within a day range of 1,680.00 to 1,745.90, while its 52-week range spans from 1,097.20 to 1,910.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.